Dilaudid and Votrient drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dilaudid (hydromorphone hydrochloride) and Votrient (pazopanib hydrochloride). Common drug interactions include hair colour changes among females and diarrhoea among males.
The phase IV clinical study analyzes what interactions people have when they take Dilaudid and Votrient. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.
What is Dilaudid?
Dilaudid has active ingredients of hydromorphone hydrochloride. It is often used in pain. eHealthMe is studying from 96,466 Dilaudid users. Check the latest studies of Dilaudid.
What is Votrient?
Votrient has active ingredients of pazopanib hydrochloride. It is often used in metastatic renal cell carcinoma. eHealthMe is studying from 25,347 Votrient users. Check the latest studies of Votrient.
79 people who take Dilaudid and Votrient together, and have interactions are studied.

What are the common drug interactions of Dilaudid and Votrient, by gender? *:
female:
- Hair colour changes
- Diarrhoea
- Hypersomnia (excessive daytime sleepiness (eds))
- Hospitalisation
- Abdominal pain
- Alopecia (absence of hair from areas of the body)
- Contusion (a type of hematoma of tissue in which capillaries)
- Dehydration (dryness resulting from the removal of water)
- Dyspepsia (indigestion)
- Hypophagia (reduced food intake)
male:
- Diarrhoea
- Death
- Hand-foot-and-mouth disease
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
- Lip ulceration (ulcer of lip)
- Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
- Neuropathy peripheral (surface nerve damage)
- Restrictive pulmonary disease (reduction in total lung capacity)
- Skin discolouration (change of skin colour)
- Thymic cancer metastatic
What are the common drug interactions of Dilaudid and Votrient, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Hair colour changes
- Nail discolouration (change in nail colour)
- Nausea (feeling of having an urge to vomit)
- Somnolence (a state of near-sleep, a strong desire for sleep)
- Acute coronary syndrome (acute chest pain and other symptoms that happen because the heart does not get blood)
- Aortic valve incompetence
- Blood pressure increased
- Bundle branch block (disruption in the normal flow of electrical pulses that drive the heart beat)
- Cardiac failure
- Chest pain
30-39:
- Death
- Burns third degree
- Gastric neoplasm (a tumour that develops in the stomach)
- Hypoaesthesia (reduced sense of touch or sensation)
- Inguinal mass
- Malignant neoplasm progression (cancer tumour came back)
- Pyrexia (fever)
- Rash
- Tumour pain
- Wound
40-49:
- Arthralgia (joint pain)
- Cough
- Death
- Decreased appetite
- Diarrhoea
- Disease progression
- Disturbance in attention
- Haemorrhage (bleeding)
- Intervertebral disc protrusion (spinal disc protrusion)
- Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
50-59:
- Nausea (feeling of having an urge to vomit)
- Vomiting
- Confusional state
- Fatigue (feeling of tiredness)
- Haemoptysis (blood-stained sputum from the bronchi, larynx, trachea, or lungs)
- Haemorrhage (bleeding)
- Abdominal discomfort
- Abdominal distension
- Abdominal pain
- Anaemia (lack of blood)
60+:
- Alanine aminotransferase increased
- Amylase increased
- Decreased appetite
- Malignant neoplasm progression (cancer tumour came back)
- Hospitalisation
- Abdominal pain upper
- Arthralgia (joint pain)
- Ascites (accumulation of fluid in the abdominal cavity)
- Aura
- Blood potassium increased
What are the existing conditions these people have? *
- Renal Cell Carcinoma (a kidney cancer): 35 people, 44.30%
- Rhabdomyosarcoma (cancer of the bone, soft tissues, or connective tissue (e.g., tendon or cartilage)): 6 people, 7.59%
* Approximation only. Some reports may have incomplete information.
Do you take Dilaudid and Votrient?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dilaudid and Votrient:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dilaudid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Votrient:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dilaudid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Votrient and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Costa DA, de Almeida SB, Barata PC, Quintela A, Cabral P, Afonso A, Silva JM, "Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach", Case Reports in Oncology, 2013 Jan .
- Costa DA, de Almeida SB, Barata PC, Quintela A, Cabral P, Afonso A, Silva JM, "Pazopanib-Induced Cutaneous Leukocytoclastic Vasculitis: An Exclusion Diagnosis of a Multidisciplinary Approach", Case Reports in Oncology, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on hydromorphone hydrochloride and pazopanib hydrochloride (the active ingredients of Dilaudid and Votrient, respectively), and Dilaudid and Votrient (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Relafen cause Bone Disorder? - 11 seconds ago
- Could Ibu cause Pharyngeal Oedema? - 11 seconds ago
- Could Clozapine cause Urine Output - Decreased? - 11 seconds ago
- Could Calcium cause Grip Strength Decreased? - 15 seconds ago
- Falmina vs. Desogestrel; Ethinyl, side effect and effectiveness comparison - 23 seconds ago
- Could Calcium cause Application Site Rash? - 29 seconds ago
- Drug interactions of Benzonatate and Rifaximin - 30 seconds ago
- Drug interactions of Doxorubicin Hydrochloride and Vitamin C - 32 seconds ago
- Could Reglan cause Heart Valve Incompetence? - 39 seconds ago
- Could Fludarabine Phosphate cause Nosebleed? - 46 seconds ago